Inhibition of Bruton’s Tyrosine Kinase Modulates Microglial Phagocytosis: Therapeutic Implications for Alzheimer’s Disease

Overview of attention for article published in Journal of Neuroimmune Pharmacology, February 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#44 of 583)
High Attention Score compared to outputs of the same age (90th percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

news: 2 news outlets

blogs: 1 blog

Readers on

mendeley: 106 Mendeley

Summary News Blogs

So far, Altmetric has seen 2 news stories from 2 outlets.

Bruton Tyrosine Kinase Inhibitors: A New Hope for the Management of Progression in MS?

Neurology Live, 02 Mar 2023

Several therapies are progressing through the development pipeline and have shown promising data, setting up the multiple…

Inhibition of Bruton's Tyrosine Kinase Modulates Microglial Phagocytosis: Therapeutic Implications for Alzheimer's Disease.

Alzforum, 15 Feb 2019

. Inhibition of Bruton's Tyrosine Kinase Modulates Microglial Phagocytosis: Therapeutic Implications for Alzheimer's Disease.